- Home
- BCLI vs SPRC Comparison
BCLI vs SPRC Comparison
Compare BCLI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- SPRC
- Stock Information
- Founded
- BCLI 2000
- SPRC 2004
- Country
- BCLI United States
- SPRC Israel
- Employees
- BCLI N/A
- SPRC N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- BCLI Health Care
- SPRC Health Care
- Exchange
- BCLI Nasdaq
- SPRC Nasdaq
- Market Cap
- BCLI 13.5M
- SPRC 11.6M
- IPO Year
- BCLI N/A
- SPRC N/A
- Fundamental
- Price
- BCLI $1.89
- SPRC $0.60
- Analyst Decision
- BCLI Strong Buy
- SPRC
- Analyst Count
- BCLI 1
- SPRC 0
- Target Price
- BCLI $30.00
- SPRC N/A
- AVG Volume (30 Days)
- BCLI 109.6K
- SPRC 24.5M
- Earning Date
- BCLI 11-14-2024
- SPRC 02-15-2025
- Dividend Yield
- BCLI N/A
- SPRC N/A
- EPS Growth
- BCLI N/A
- SPRC N/A
- EPS
- BCLI N/A
- SPRC N/A
- Revenue
- BCLI N/A
- SPRC $1,747,000.00
- Revenue This Year
- BCLI N/A
- SPRC N/A
- Revenue Next Year
- BCLI N/A
- SPRC N/A
- P/E Ratio
- BCLI N/A
- SPRC N/A
- Revenue Growth
- BCLI N/A
- SPRC N/A
- 52 Week Low
- BCLI $1.05
- SPRC $0.20
- 52 Week High
- BCLI $11.85
- SPRC $6.78
- Technical
- Relative Strength Index (RSI)
- BCLI 44.80
- SPRC 52.60
- Support Level
- BCLI $1.90
- SPRC $0.63
- Resistance Level
- BCLI $2.17
- SPRC $0.91
- Average True Range (ATR)
- BCLI 0.18
- SPRC 0.22
- MACD
- BCLI -0.05
- SPRC -0.00
- Stochastic Oscillator
- BCLI 4.76
- SPRC 16.95
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.